Cellectis
CLLS
$2.56
Share price
1.59%
Change (1 day)
31.28%
Change (1 year)
Categories
EPS for Cellectis (CLLS)
EPS in 2023 (TTM): -$1.99
According to Cellectis's latest financial reports the company's current EPS (TTM) is -$1.99. In 2022 the company made an earnings per share (EPS) of -$2.34 an increase over its 2021 EPS that were of -$2.93.
EPS history for Cellectis from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.99 | -14.96% |
| 2022 | -$2.34 | -20.14% |
| 2021 | -$2.93 | 50.26% |
| 2020 | -$1.95 | -19.09% |
| 2019 | -$2.41 | 23.59% |
| 2018 | -$1.95 | -30.36% |
| 2017 | -$2.80 | 45.81% |
| 2016 | -$1.92 | 198.35% |
| 2015 | -$0.64 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $37.36 | -1,977.39% | 🇺🇸 USA |
 uniQure QURE | -$3.94 | 97.99% | 🇳🇱 Netherlands |
 Novavax NVAX | -$7.19 | 261.31% | 🇺🇸 USA |